Aims/hypothesis Precise regulation of insulin secretion by the pancreatic beta cell is essential for the maintenance of glucose homeostasis. Insulin secretory activity is initiated by the stepwise breakdown of ambient glucose to increase cellular ATP via glycolysis and mitochondrial respiration. Knockout of Lkb1, the gene encoding liver kinase B1 (LKB1) from the beta cell in mice enhances insulin secretory activity by an undefined mechanism. Here, we sought to determine the molecular basis for how deletion of Lkb1 promotes insulin secretion. Methods To explore the role of LKB1 on individual steps in the insulin secretion pathway, we used mitochondrial functional analyses, electrophysiology and metabolic tracing coupled with by gas chromatography and mass spectrometry. Results Beta cells lacking LKB1 surprisingly display impaired mitochondrial metabolism and lower ATP levels following glucose stimulation, yet compensate for this by upregulating both uptake and synthesis of glutamine, leading to increased production of citrate. Furthermore, under low glucose conditions, Lkb1 −/− beta cells fail to inhibit acetyl-CoA carboxylase 1 (ACC1), the rate-limiting enzyme in lipid synthesis, and consequently accumulate NEFA and display increased membrane excitability. Conclusions/interpretation Taken together, our data show that LKB1 plays a critical role in coupling glucose metabolism to insulin secretion, and factors in addition to ATP act as coupling intermediates between feeding cues and secretion. Our data suggest that beta cells lacking LKB1 could be used as a system to identify additional molecular events that connect metabolism to cellular excitation in the insulin secretion pathway.
Introduction
The initiating steps in the glucose-stimulated insulin secretion (GSIS) pathway involve the stepwise breakdown of glucose through glycolysis and oxidation of the glycolytic product, pyruvate, in mitochondria. ATP-sensitive potassium channels (K ATP channels) on the plasma membrane sense the increase in ATP and consequently close [1] [2] [3] [4] , triggering membrane depolarisation and opening of voltage-sensitive L-type Ca 2+ channels [4, 5] . The secretory response is biphasic; within minutes a readily releasable pool (RRP) of granules docked at the plasma membrane is released [6] [7] [8] . A second phase, which requires recruitment and trafficking of insulin granules to the plasma membrane, follows [9] . The central role of the K ATP channel in beta cell function is highlighted by deficiencies in both first and second phase GSIS in islets from sulfonylurea 1 (SUR1) −/− and ATP-sensitive inward rectifier potassium channel (KIR6.2) −/− mice [10] . In humans, inappropriate inhibition or activation of K ATP channel activity arising from mutations in KIR6.2 and SUR1 underlie congenital hyperinsulinaemia or neonatal diabetes, respectively [11] [12] [13] . Our understanding of precisely how glucose is coupled to insulin output is still incomplete. Several lines of evidence have indicated that the secretory response is more intricate than the classical model outlined above would suggest. For example, an increase in cytosolic ATP and closure of K ATP channels does not always correlate with insulin output in GSIS [10] . Beta cells can also secrete insulin independently of K ATP channel closure by an unclear mechanism that still requires calcium influx and membrane depolarisation [10, 14] . Furthermore, K ATP channel activity can be recorded from oncell patches on beta cells exposed to glucose-free solutions, despite the fact that the intracellular ATP concentration under similar conditions would predict the channels to be closed [15] . Finally, the presence of depolarising agents and the allosteric K ATP channel activator diazoxide can further enhance insulin secretion in response to glucose [16] . As a result, additional factors that drive metabolism-dependent secretion, such as mitochondrial metabolites (NADPH, GTP, phosphoenol pyruvate [PEP] , α-ketoglutarate [α-KG]), and other secondary glucose-derived metabolites such as glutamate [17, 18] must exist.
We previously demonstrated that Lkb1 adult beta cell knockout (LABKO) mice are resistant to hyperglycaemia induced by a high-fat diet, owing in large part to a doubling of beta cell mass and enhanced insulin stores via mTOR activation [19] . However, targeting liver kinase B1 (LKB1) in the beta cell for the treatment of diabetes would be undesirable as knockout of Lkb1 in adult mice has a deleterious effect on haematopoietic stem cell maturation [20] [21] [22] . We and others have identified non-overlapping functions in beta cells for LKB1 targets, including MAP/microtubule affinityregulating kinase 2 (MARK2), salt-inducible kinase 2 (SIK2), brain-specific kinase 2 (BRSK2) as well as AMPactivated protein kinase (AMPK) itself [19, [23] [24] [25] [26] [27] [28] , underscoring the potential for identifying the minimal target(s) of LKB1 responsible for enhancing insulin secretion. Here, we systematically interrogated insulin secretion pathway components to identify the signals responsible for enhanced insulin secretion in Lkb1 knockout islets.
Methods
Animals Control LoxP/LoxP (L/L) and LABKO mice were obtained from mating homozygous Lkb1 floxed mice to Pdx1-CreER tam mice all on an FVB/n background as described previously [19] (electronic supplementary material [ESM] Methods).
Antibodies and short hairpin RNA sequences Antibodies and short hairpin RNA (shRNA) sequences are included in ESM Methods.
GSIS and calcium experiments GSIS and calcium experiments were performed as described previously [19] (ESM Methods).
Electron microscopy and insulin immunogold labelling Pancreases were fixed in 2.6% glutaraldehyde overnight and processed as described previously [29] (ESM Methods).
Seahorse measurements Measurements of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were performed as described previously [23] (ESM Methods).
Mitochondrial membrane potential and content measurements Mitochondrial inner membrane potential was measured in disperse d i s l e t c e l l s u s i n g tetramethylrhodamine ethyl ester (TMRE) and normalised to Mitotracker green (MTG; Invitrogen, Burlington, ON, Canada) intensity (ESM Methods).
NAD(P)H autofluorescence imaging
Islets were incubated in 2 mmol/l glucose for 1 h and loaded into microfluidic devices and placed in a heating chamber on a Zeiss LSM710 microscope (Zeiss Canada, Toronto, ON, Canada) and imaged as described previously [30] .
NEFA quantification in islets NEFA levels in chloroform extracts from 50 islets per mouse were determined using a colorimetric assay (Abcam, Toronto, ON, Canada).
Membrane potential recordings and whole cell patchclamp Plasma membrane potential and voltage-dependent K channel activity was measured using a perforated patch technique in whole cell configuration as described previously [31, 32] (ESM Methods). C 5 ]glutamine for the indicated times and compared with starved and unlabelled carbon source samples. GC-MS analysis was performed as described previously [33] (ESM Methods).
Metabolomics
Measurement of ATP/ADP nucleotides Cells were processed for extraction of cell nucleotides as described previously [34] (ESM Methods).
Results
Loss of LKB1 in mouse beta cells increases insulin granule size and plasma membrane docking We previously reported that islets lacking LKB1 in the beta cell compartment led to a twofold increase in insulin content per cell [19] . As the proximity of insulin granules to the plasma membrane dictates the amplitude of first phase insulin release, we evaluated the size of the RRP in LABKO islets. Electron microscopy revealed that the number of insulin granules docked at the plasma membrane was 60% greater in LABKO beta cells, which correlated well with the 1.9-fold increase in first phase GSIS (Fig. 1a, b ). Insulin immunogold labelling revealed a greater than twofold increase in the number of insulinpositive particles per granule, and a greater than threefold increase in the number of large granules (>900 nm diameter; ESM Fig. 1 ).
LKB1 regulates glucose sensing We previously observed an enhanced rate of calcium influx in response to glucose in LKB1 knockdown (LKB1i) MIN6 cells, raising the possibility that LKB1 regulates sensitivity to feeding cues. To determine if glucose responsiveness is enhanced in the absence of LKB1, we performed islet perifusion experiments. A glucose ramp (2.8 to 16.7 mmol/l) revealed an increase in maximal release at near saturating glucose concentrations in the GSIS response curve, with the response from LABKO islets to 8 mmol/l glucose equal to that of L/L control islets to 16.7 mmol/l glucose (Fig. 1c) . Taken together, these data suggest that, in addition to having an increase in insulin cargo per cell, LABKO beta cells are also more sensitive to glucose. LKB1 depletion increases sensitivity to the anti-diabetic drug tolbutamide To determine if the K ATP channel was functionally altered in cells lacking LKB1, we monitored insulin secretion in response to tolbutamide, which belongs to a class of sulfonylurea drugs used to treat type 2 diabetes. Binding of tolbutamide to the SUR1 subunit of the K ATP channel results in channel closure, membrane depolarisation and insulin secretion. Following treatment of MIN6 cells expressing control non-silencing shRNA with 200 μmol/l tolbutamide, we observed an eightfold stimulation of insulin secretion in 1 mmol/l (low) glucose and 17-fold stimulation in the presence of 20 mmol/l (high) glucose (Fig. 2a) . Interestingly, following knockdown of LKB1, MIN6 cells in low glucose responded to tolbutamide as though they were cultured in stimulatory glucose concentrations (Fig. 2a) . This effect was also seen in perifused LABKO islets, which unlike islets from control (L/L) animals, secreted insulin in response to tolbutamide in low glucose (Fig. 2b) . Treatment of LABKO islets with mitiglinide, a secretagogue that closes the K ATP channel without binding to SUR1, produced similar results (Fig. 2c) . To determine if closure of the K ATP channel was required for the observed sensitisation, we stimulated LABKO islets with increasing amounts of tolbutamide in the presence of diazoxide, which opens the K ATP channel and prevents membrane depolarisation and insulin secretion [35] . As shown in Fig. 2d , both LABKO and control islets responded to tolbutamide in the presence of diazoxide, indicating that if LKB1 acts on the K ATP channel it likely does so in a SUR1-independent manner, a mechanism that has been reported for glucosestimulated secretion (reviewed in [36] ).
Enhanced membrane depolarisation and calcium influx in LABKO beta cells The sensitivity to tolbutamide in LABKO cells suggested that closure of K ATP channels could occur at a lower threshold, either because there are fewer channels present, or because the channels are more primed for closure at steady state. Whole cell patch-clamp analysis showed that LABKO beta cells fire action potentials (APs) at sixfold lower concentration of tolbutamide than control beta cells (100 μmol/l for control L/L, 15 μmol/l for LABKO; Fig. 3a, b) , and that the frequency of APs in LABKO beta cells increased twofold to fivefold overall at either concentration of drug (Fig. 3b) . Surprisingly, both resting membrane potential and the magnitude of depolarisation in response to glucose treatment were similar in control and LABKO beta cells, suggesting that K ATP channel closure is still dynamically regulated ( Fig. 3c; ESM Fig. 2a) . Furthermore, the K ATP channel density was the same in L/L and LABKO beta cells (Fig. 3d) . Importantly, there was no change in expression of K ATP channel subunits in MIN6 LKB1i cells or LABKO islets, and no enhancement in K ATP channel closure in LABKO islets following glucose treatment (ESM Fig. 2b ). These data indicate that loss of LKB1 enhances cellular excitability through promoting calcium influx and not through regulating K ATP channel closure.
Consistent with the increased tolbutamide-induced membrane depolarisation, maximal calcium response to tolbutamide in MIN6 cells was achieved at a tenfold lower concentration after silencing LKB1 (Fig. 3e) , while calcium levels under basal conditions were unaffected (ESM Fig. 3a) . A similar effect was observed in dispersed LABKO beta cells (ESM Fig. 4a) . Treatment with the L-type specific calcium channel inhibitor diltiazem blocked this influx, indicating that the extracellular milieu and not intracellular stores was the source of calcium ions (ESM Fig. 4a, b) . Taken together, these data reveal that LABKO beta cells secrete more insulin in part due to sensitisation of calcium influx.
LKB1 is required for mitochondrial respiration in beta cells Mitochondrial oxidative phosphorylation using the glycolytic end-product pyruvate generates ATP that closes K ATP (Fig. 1b) prompted us to test whether loss of LKB1 enhances mitochondrial function. In control MIN6 cells and control (L/L) islets, the OCR increased in response to glucose (Fig. 4a, b) . By contrast, LKB1 knockdown MIN6 cells and LABKO islets displayed a global reduction in OCR, to levels at or below which control MIN6 cells and L/L islets OCR respired following treatment with oligomycin, an inhibitor of mitochondrial F1Fo-ATP synthase (Fig. 4a, b) . The effects on both respiration and insulin secretion were specific to loss of LKB1, as reconstitution of LKB1 in LABKO islets restored the OCR (Fig. 4c) and reduced GSIS in both primary mouse islets (Fig. 4b) and LABKO islets (ESM Fig. 5a ). These data indicate a surprising uncoupling of insulin secretory capacity and mitochondrial bioenergetics in beta cells lacking LKB1. MIN6 cells, unlike primary islets [37] , will metabolise pyruvate and consequently secrete insulin. Interestingly, provision of pyruvate or the anaplerotic substrate glutamine (see below) individually or in combination restored OCR in both basal and uncoupled states in cells lacking LKB1 (Fig. 4c, d; ESM Fig. 5b, c) . Normal OCR was restored when green fluorescent protein (GFP)-tagged LKB1 was introduced into LABKO islets (Fig. 4e) or by overexpression of a constitutively active AMPK (AMPK-T172D), indicating that loss of AMPK activity at least in part resulted in the respiratory defect (ESM Fig. 5d ). Consistent with this, overexpression of LKB1 in control islets inhibited secretion (Fig. 4f) .
The reduction in medium ECAR in LABKO cells (ESM Fig. 5b ) suggested that impaired generation of a metabolic intermediate may underlie the defect in mitochondrial respiration. Indeed, we observed a reduced ATP/ADP ratio in MIN6 cells (Fig. 4g) as well as lower ATP levels and mitochondrial membrane potential (ΔΨ) in LABKO islets ( Fig. 4h;  ESM Fig. 6 ). These changes occurred without a reduction in mitochondrial mass (ESM Fig. 7 ). These data indicate that if provided with sufficient fuel, the electron transport chain (ETC) in LKB1-deficient cells can support electron transport.
Increased glutamine flux in beta cells lacking LKB1 To determine if impaired bioenergetics in LABKO cells was due to a defect in generation of mitochondrial fuel, we assessed the metabolic flux of glucose in LABKO islets by GC-MS. Following timed pulses with 10 mmol/l [ 13 C 6 ]glucose, there was an overall trend towards increased total pyruvate in MIN6 cells silenced for Lkb1, derived from both labelled ( 13 C) and unlabelled ( 12 C) sources (Fig. 5a, b) . A significant increase in pyruvate was only observed in the relative abundance of [ 12 C]pyruvate after 120 min, consistent with a reduction in its rate of production from glucose. We also observed a significant increase in unlabelled citrate in the absence of LKB1 at all time points (Fig. 5b) . However, the proportion of 13 C-labelling of citrate from glucose was similar in cells lacking LKB1, suggesting that tricarboxylic acid (TCA)-derived citrate from glucose was reduced, in a similar fashion to pyruvate. Following Lkb1 silencing, glucose flux to α-KG was also decreased, suggesting the excess pyruvate and citrate have an alternate fate besides cycling through the TCA cycle.
Interestingly, levels of glucose-derived glutamine were elevated in LKB1 knockdown cells (Fig. 5b) , which can be used as an alternative cellular carbon source for anabolic processes. To identify the fate of glutamine, we pulsed MIN6 cells with 2 mmol/l [ 13 C 5 ]glutamine for 10 and 60 min and measured incorporation into several intermediate metabolites using GC-MS (Fig. 5c) . In cells silenced for Lkb1, there was a trend towards increased glutamine uptake and levels of glutamate, as well as a significant early increase in α-KG levels (Fig. 5d) . Furthermore, while pyruvate levels were unaffected, citrate production from glutamine was significantly increased at all time points (Fig. 5d and data not shown) . Taken together, these data indicate that in beta cells lacking LKB1, the breakdown of glucose is enhanced, resulting in an increase in citrate and glutamine abundance. That this occurs in the absence of a corresponding increase in glucose-derived TCA intermediates indicates that citrate is being redirected away from the TCA cycle and used for other biosynthetic pathways. Consistent with this observation, labelled carbons from glutamine contribute less to α-KG than to citrate, suggesting that this pool of citrate is shunted away from α-KG production.
Enhanced acetyl-CoA carboxylase 1 activity is required for insulin in LABKO islets To determine if changes in reductive potential accompany the enhanced insulin secretion phenotype in cells lacking LKB1, we measured levels of NAD(P)H, a proposed coupling factor for insulin secretion, in both mitochondrial and cytosolic fractions. While we observed glucose-dependent increases in NAD(P)H levels, these were unaffected by silencing Lkb1 (Fig. 6a) . Recent evidence indicates that in cancer cells, increased citrate can be generated in a reverse reaction that uses glutamine as a substrate known as reductive carboxylation [38] . Reductive carboxylation provides carbon for fatty acid synthesis and drives the accumulation of long chain fatty acids [38] . We therefore measured levels of NEFA (of longer than eight carbons) in LABKO islets and found they were increased twofold compared with control islets (Fig. 6b) . Using labelled glucose and glutamine during 24 h to trace NEFA in LKB1i cells, we were unable to identify which NEFA was increased in LKBi cells, mainly due to the very small proportion of NEFA being produced from both glucose and glutamine (data not shown). However consistent with the overall increase of NEFA LABKO islets, phosphorylation of acetyl-CoA carboxylase 1 (ACC1; at the AMPK site Ser79 [39] ) was reduced by 50% in LABKO islets, indicative of inappropriate ACC1 activation under low glucose conditions, which we attribute to a loss of AMPK activity (Fig. 6c) . These observations suggest that ACC1-dependent lipid accumulation may be important for insulin secretion; indeed, knockdown of ACC1 blocked insulin secretion in MIN6 cells and in mouse islets even when Lkb1 was silenced ( Fig. 6d; ESM Fig. 8 ). Taken together, these data show that LKB1 functions to restrain glucosestimulated calcium influx and insulin secretion by attenuating ACC1 activity and the generation of glutamine-derived citrate (see model in Fig. 7 ).
Discussion
LKB1 depletion uncouples glucose metabolism from calcium influx and insulin secretion We and others previously reported that deletion of Lkb1 in adult mouse beta cells leads to increased insulin secretion [19, 26] . Here, we report that LKB1 acts to attenuate K ATP channel closure and calcium influx. This is evidenced by an enhanced closure of K ATP channels, calcium influx and insulin secretion in response to tolbutamide in LABKO beta cells, even in the absence of glucose. Given the reduction in energy status in LABKO beta cells under both basal and stimulated conditions, the enhancement in insulin secretion is paradoxical. Taken together, our data are consistent with the notion that LKB1 regulates both exocytotic events as well as metabolic amplification of calcium influx through an alternate coupling factor that is not ATP and involves citrate and ACC1.
Metabolic rewiring in LABKO beta cells That impaired mitochondrial respiration in LABKO islets can be restored with constitutively active AMPK indicates the LKB1-AMPK pathway may directly control mitochondrial bioenergetics. While provision of additional substrate can restore full ETC activity in beta cells lacking LKB1, following glucose stimulation there is a reduction by half in their bioenergetic capacity. Furthermore, in the absence of LKB1, glucose usage favours citrate and glutamine production, and glucose-derived glutamine is used to generate citrate, contributing to higher citrate levels. This metabolic shift towards glutaminolysis may help to maintain both the higher basal mitochondrial membrane potential and NADPH levels in LABKO β cells in which respiration is attenuated. Glutamine itself is known to amplify GSIS and enhance K ATP channel-independent release [40] , and may serve as a coupling factor to amplify metabolism-secretion coupling in LABKO beta cells. This idea is consistent with recent work using beta cells in which Lkb1 is deleted (using the Ins1-Cre system), wherein loss of LKB1 or AMPK results in a metabolic switch favouring glutamine metabolism [27] . Taken together, it appears that in cells lacking LKB1, fuel is redirected away from the TCA cycle to favour biosynthetic pathways such as amino acid synthesis, or NEFA and lipid generation for de novo granule generation, or perhaps for use in a signalling role. As ACC1 has been shown to be required for pyruvate cycling and generation of TCA intermediates [41, 42] , we conclude that enhanced insulin secretion from LABKO beta cells is due at least in part to enhanced ACC1 activity and increased citrate production from glutamine. Taken together, these observations support the idea that activating ACC1 or elevating citrate levels may be beneficial for enhancing insulin secretion in settings of hypoinsulinaemia.
